Early Discharge in Breast Cancer Surgery: Safety and Patient Satisfaction with the Outpatient Approach Meme Kanseri Cerrahisinde Erken Taburculuk: Günübirlik Cerrahi Yaklaşımının Güvenlik ve Hasta Memnuniyeti

Creative Commons License

Kültüroğlu M. O., Aydın F., Aslan F., Sağdıç M. F., AKSEL B., DOĞAN L.

Anatolian Journal of General Medical Research, cilt.35, sa.3, ss.301-306, 2025 (Scopus, TRDizin)

Özet

Objective: Advances in minimally invasive surgery and anesthesia have enabled same-day discharge after breast cancer surgery. This study compared outcomes, complication rates, and patient satisfaction between patients discharged on the same-day of breast-conserving surgery with sentinel lymph node biopsy and patients discharged the following day. Methods: Between December 2022 and May 2025, 349 patients with early-stage breast cancer at University of Health Sciences Türkiye, Ankara Etlik City Hospital were enrolled in the study. Same-day discharge was offered to patients who underwent general anesthesia with a laryngeal mask, had no drains or significant comorbidities, and demonstrated stable postoperative recovery. Patients accepting same-day discharge formed the outpatient group (n=215), and those who declined formed the inpatient group (n=134). Demographics, tumor characteristics, 30-day complications (Clavien-Dindo classification), and patient satisfaction (BREAST-Q) were recorded. Results: The groups were comparable in terms of demographics and tumor features. The rates of seroma (6% vs. 6.7%), partial skin necrosis (1.4% vs. 1.5%), and surgical-site infection (1.9% vs. 1.5%) were similar (p>0.05). No major complications occurred. Overall, 90.5% of the patients experienced no complications, with minor complication rates comparable between the groups. BREAST-Q scores were slightly higher in the same-day discharge group (satisfaction: 94±4.6 vs. 92±6.3; psychosocial well-being: 91±3.8 vs. 89±4.5), although these differences were not statistically significant. Conclusion: Outpatient breast-conserving surgery with sentinel lymph node biopsy is safe, feasible, and associated with high patient satisfaction in both groups, with no significant differences between the groups in carefully selected patients with early-stage disease who do not require axillary dissection or neoadjuvant therapy. Multicenter prospective studies are needed to evaluate long-term outcomes and optimize patient selection.